NCT06458374Recruiting
ATTR Cardiac Amyloidosis in a Selected Population
Prevalence and Long Tem Follow up of ATTR Cardiac Amyloidosis in a Selected Population of Patients Operated on Carpal Tunnel Syndrome
Source: ClinicalTrials.gov · Last updated 12 Aug 2026
Brief summary (registry, in English)
Patients operated for carpal tunnel syndrome (CTS) at Ålesund Hospital (200 patients) will have a biopsy to diagnose ATTR amyloidosis. Patients with positive biopsy will be examined to decide wether they have cardiac amyloidosis. All patients with positive biopsy will be followed closely for 10 years wit echocardiography an clinically.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 180 (estimated)
- First submitted
- 7 Jun 2024
- Start date
- 1 Sept 2024
- Primary completion date
- 28 Feb 2034
- Lead sponsor
- Helse Møre og Romsdal HF
- Diseases
- Amyloidosis
- NCT number
- NCT06458374
What you commit to
- Study type: Observational
- Planned participants: 180
- From 1 Sept 2024 to the primary completion date, 28 Feb 2034
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Cardiac disease at time of operation for CTS
Age
- cannot be followed \> 5 years due to other medical conditions
Other
- not consented
- do not speak Norwegian
- secondary cause of CTS as traumatic or rheumatic
Who the study is looking for
- Male \> 50 years
- Female \> 60 years
- operated CTS at Ålesund Hospital
Age in the registry: 50 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Ålesund Hospital Coordinator of this site? Confirm its status | Ålesund | Norway | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.